Paula C Dias

发表

Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis

J. Ramalho-Carvalho, Jorge Oliveira, R. Henrique, 2013, Journal of cellular and molecular medicine.

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma

J. Ramalho-Carvalho, L. Antunes, Jorge Oliveira, 2017, British Journal of Cancer.

Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.

L. Antunes, Jorge Oliveira, R. Henrique, 2014, European journal of cancer.

Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients

J. Ramalho-Carvalho, R. Henrique, C. Jerónimo, 2010, BMC Cancer.

Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

Jorge Oliveira, R. Henrique, C. Jerónimo, 2020, Cancers.

Prognostic significance of MST1R dysregulation in renal cell tumors.

J. Ramalho-Carvalho, L. Antunes, Jorge Oliveira, 2016, American journal of cancer research.

A founder SDHB mutation in Portuguese paraganglioma patients.

P. Soares, M. Sobrinho-Simões, Jorge Lima, 2013, Endocrine-related cancer.

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

L. Antunes, Jorge Oliveira, R. Henrique, 2015, Epigenetics.

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization

L. Antunes, Jorge Oliveira, R. Henrique, 2017, Epigenetics.

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition

I. Bernard-Pierrot, Hélène Neyret-Kahn, C. Jerónimo, 2023, International journal of biological sciences.